[ad_1] Mankind Pharma has pledged an additional 56.31% of its equity shares in Bharat Serums and Vaccines Ltd (BSV), its wholly owned subsidiary, to Catalyst Trusteeship Ltd as part of the terms for securing its listed non-convertible debentures (NCDs). Company Value Change %Change “…as per the terms and conditions of 3 Debenture Trust Deeds executed […]
Mankind Pharma set to launch QIP to raise ₹3,000 crore: sources – CNBC TV18
[ad_1] Mankind Pharma is set to launch a Qualified Institutional Placement (QIP) to raise up to ₹3,000 crore, according to sources. The indicative issue price for the QIP is expected to be approximately ₹2,520 per share, which could lead to an equity dilution of 2.9% on a post-issue basis, sources added. Company Value Change %Change […]